Thermo Fisher Scientific IGFBP5 Monoclonal Antibody (145619)

Applications

Tested Dilution

Publications

Western Blot (WB)

1 µg/mL

-

ELISA (ELISA)

0.1-0.4 µg/mL (Detection), 2-8 µg/mL (Capture)

-

Product Specifications

Species Reactivity

Human

Host/Isotype

Mouse / IgG1

Class

Monoclonal

Type

Antibody

Clone

145619

Immunogen

Mouse myeloma cell line NS0-derived recombinant human IGFBP-5 Glu28-Glu272 if (typeof window.$mangular === undefined || !window.$mangular) { window.$mangular = {}; } $mangular.antigenJson = \[{targetFamily:IGFBP5,uniProtId:P24593-1,ncbiNodeId:9606,antigenRange:28-272,antigenLength:272,antigenImageFileName:MA5-23872_IGFBP5_P24593-1_House_mouse.svg,antigenImageFileNamePDP:MA5-23872_IGFBP5_P24593-1_House_mouse_PDP.jpeg,sortOrder:1}\]; $mangular.isB2BCMGT = false; $mangular.isEpitopesModalImageMultiSizeEnabled = true;

View immunogen .st0{fill:#FFFFFF;} .st1{fill:#1E8AE7;}

Conjugate

Unconjugated Unconjugated Unconjugated

Form

Lyophilized

Concentration

0.5 mg/mL

Purification

Protein A/G

Storage buffer

PBS with 5% trehalose

Contains

No Preservative

Storage conditions

-20° C, Avoid Freeze/Thaw Cycles

Shipping conditions

Ambient (domestic); Wet ice (international)

RRID

AB_2609131

Product Specific Information

In ELISAs, this antibody shows 5% cross-reactivity with recombinant mouse (rm) IGFBP-5 and no cross-reactivity with rhIGFBP-2, -3, -4, -6, rmIGFBP-1, -2, -3, -6, rhIGFBP-rp1, rmIGF-I, rmIGF-II, rhIGF-I, or rhIGF-II. In Western blots, this antibody does not cross-react with rhIGFBP-1, -2, -3, -4, -6, or -7.

Reconstitute at 0.5 mg/mL in sterile PBS.

Target Information

The insulin-like growth factor-binding proteins, or IGFBPs, are a family of homologous proteins that have co-evolved with the IGFs. They serve not only as shuttle molecules for the soluble IGFs, but also confer a level of regulation to the IGF signaling system. Physical association of the IGFBPs with IGF influences the bio-availability of the growth factors, as well as their concentration and distribution in the extracellular environment. In addition, the IGFBPs appear to have biological activity independent of the IGFs. Seven IGFBPs have thus far been described, each differing in their tissue distribution, half-lives and modulation of IGF interactions with their receptors. For instance, IGFBP1 is negatively regulated by insulin production. The IGFBP1 gene is expressed at a high level during fetal liver development and in response to nutritional changes and diabetes. It has been suggested that IGFBP2 functions as chaperone, escorting IGFs to their target tissues. It is expressed in several human tissues including fetal eye and fetal brain. IGFBP3 is the most abundant IGFBP and is complexed with roughly 80% of the serum IGFs. Both IGFBP3 and IGFBP4 are released by dermal fibroblasts in response to incision injury. IGFBP5 is secreted by myoblasts and may play a key role in muscle differentiation.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.